A quote form today's SMH:
http://www.smh.com.au/business/sigma-suspended-as-accounts-reworked-20100301-pcce.html
"However, BusinessDay can rule out at this stage any concerns the financial problems are linked to misappropriation of funds or its recent acquisition of a pharmaceutical brand portfolio and manufacturing facility from global pharmaceutical firm Bristol-Myers Squibb."
So now SIP is suspended while they rework on the accounts. Assuming that the accounts irregularity isn't related to those suggested in the article, I guess we'll just have to wait and see.
Add to My Watchlist
What is My Watchlist?